휴대용 산소발생기 세계 시장 규모는 2023년 18억 달러에 달했습니다. 향후 IMARC Group은 2024-2032년 연평균 성장률(CAGR)이 7.3%로 2032년까지 시장 규모가 34억 달러에 달할 것으로 예측했습니다. 만성폐쇄성폐질환, 천식, 낭포성 섬유증 등 호흡기 질환의 발병률 증가, 재택의료 선호도 증가, 노령인구 증가 등이 시장을 견인하는 주요 요인 중 하나입니다.
휴대용 산소발생기(POC)는 호흡기 질환 환자에게 농축된 산소를 공급하는 의료기기입니다. 이동 중에도 산소 치료를 할 수 있도록 설계되어, 환자는 기존의 의료 환경 밖에서도 활동적인 생활 방식을 유지하면서 필요한 산소 지원을 받을 수 있습니다. 이 농축기는 산소 실린더나 고정식 농축기에 의존하는 기존 산소 치료 방식과 달리 작고 가벼워 휴대가 간편합니다. 주변 공기를 흡입하여 질소 및 기타 가스를 걸러내고 고농도의 산소를 사용자에게 공급하는 방식으로 작동합니다.
이 시장을 주도하는 것은 주로 이산화탄소(CO2) 배출로 인한 환경 오염 증가입니다. 또한, 산소 농도가 부족한 지역에서의 여행자 및 등산객의 POC에 대한 수요 증가도 시장 성장의 주요 요인으로 작용하고 있습니다. 이 외에도 기술 발전도 시장 성장에 크게 기여하고 있습니다. 시장 개척자들은 환자의 휴대성과 편의성을 향상시킬 수 있는 가볍고 컴팩트하며 사용하기 쉬운 기기를 개발하기 위한 기술 혁신을 지속하고 있으며, 이는 시장 성장에 기여하고 있습니다. 또한, 전 세계적으로 헬스케어 인프라에 대한 지출이 증가하고 있는 것도 시장 성장을 가속하고 있습니다. 또한, 이동이 용이하여 수면무호흡증 환자를 위한 휴대용 산소발생기에 대한 수요가 증가하고 있으며, 이는 전 세계적으로 좋은 시장 전망을 형성하고 있습니다.
호흡기 질환 증가
폐암, COPD, 천식, 폐섬유증, 독감 등 호흡기 질환 진단을 받는 환자가 증가함에 따라 효과적인 산소 치료 솔루션이 필요하며, POC는 환자에게 산소를 공급할 수 있는 휴대용의 편리한 옵션을 제공하여 환자의 상태를 관리하고 삶의 질을 향상시킬 수 있도록 합니다. 환자의 상태를 관리하고 삶의 질을 향상시킬 수 있습니다. 호흡기 질환의 유병률 증가는 시장에서 POC에 대한 수요 증가에 직접적으로 기여하고 있습니다. 또한, POC는 의료 서비스 제공업체가 병원의 벽을 넘어 진료를 확대하여 재택 산소 요법을 촉진하고 의료 시설의 부담을 줄일 수 있습니다. 또한 POC는 기존의 산소 요법과 비교하여 빈번한 실린더 리필 및 고정식 농축기 유지 보수가 필요하지 않기 때문에 비용 효율적인 솔루션이 될 수 있습니다.
재택의료에 대한 선호도 증가
재택치료는 환자가 병원이나 진료소에 갇히지 않고 치료를 받을 수 있는 휴대용 의료기기의 필요성을 강조하고 있으며, POC는 집에서 산소 요법을 할 수 있는 편리하고 가벼운 솔루션을 제공함으로써 이러한 요구 사항에 부합합니다. 그 결과, 재택치료에 대한 선호도가 높아지면서 휴대용 산소발생기에 대한 수요가 증가하고 있습니다. 또한, 재택치료는 입원, 재입원, 응급실 방문을 줄임으로써 의료 시스템에서 비용을 절감할 수 있으며, POC는 환자가 집에서 산소 요법을 받을 수 있도록 하여 호흡기 질환과 관련된 입원의 필요성을 최소화할 수 있습니다. 이러한 의료 자원의 최적화와 비용 효율성은 POC를 재택치료 전략에 통합하는 원동력이 되고 있습니다.
노령인구 증가
노년기에는 만성폐쇄성폐질환(COPD), 폐렴 및 기타 폐 관련 질환과 같은 호흡기 질환에 걸릴 위험이 높아집니다. 이러한 질환은 증상을 관리하고 삶의 질을 개선하기 위해 장기적인 산소 요법을 필요로 하는 경우가 많습니다. 결과적으로 노인 인구 증가는 호흡기 질환의 유병률 증가에 직접적으로 기여하고 있으며, 이는 산소 치료에 필수적인 의료기기로서 POC에 대한 수요 증가로 이어지고 있습니다. 또한, POC는 노인들이 필요한 산소 지원을 받으면서도 활동적인 라이프스타일을 지속하는 데 필요한 이동성과 휴대성을 제공합니다. 노년층의 액티브 에이징에 대한 열망은 그들이 원하는 활동에 완전히 참여할 수 있도록 하는 POC에 대한 수요를 주도하고 있습니다.
The global portable oxygen concentrators market size reached US$ 1.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 3.4 Billion by 2032, exhibiting a growth rate (CAGR) of 7.3% during 2024-2032. The rising incidences of respiratory diseases such as chronic obstructive pulmonary disease, asthma, and cystic fibrosis, the growing preference for home-based medical care, and the increasing geriatric population are some of the major factors propelling the market.
Portable oxygen concentrators (POCs) are medical devices that provide a concentrated supply of oxygen to individuals with respiratory conditions. They are designed to deliver oxygen therapy on-the-go, allowing patients to maintain an active lifestyle and receive the necessary oxygen support outside of traditional healthcare settings. These concentrators are compact, lightweight, and easily transportable unlike traditional oxygen therapy methods that rely on oxygen cylinders or stationary concentrators. They operate by drawing in ambient air, filtering out nitrogen and other gases, and delivering a higher concentration of oxygen to the user.
The market is primarily driven by the increasing amount of environmental pollution due to carbon dioxide (CO2) emissions. In addition, the escalating demand for POCs by travelers and mountaineers in places wherein the oxygen level is inadequate represents another major growth-inducing factor. Besides, technological advancements have significantly contributed to the growth of the market. Manufacturers are continuously innovating to develop lightweight, compact, and user-friendly devices that offer enhanced portability and convenience for patients, which is also augmenting the market growth. Moreover, the growing expenditure on healthcare infrastructure across the globe is also propelling the market growth. Furthermore, the rising demand for portable oxygen concentrators for the patients suffering from sleep apnea due to its easy of mobility, is creating a favorable market outlook across the globe.
The rising incidences of respiratory diseases
The growing number of individuals diagnosed with respiratory diseases such as lung cancer, COPD, asthma, pulmonary fibrosis, and flu, necessitates the availability of effective oxygen therapy solutions. POCs offer a portable and convenient option for delivering oxygen to patients, enabling them to manage their conditions and improve their quality of life. The rising incidences of respiratory diseases are directly contributing to the increased demand for POCs in the market. Moreover, POCs enable healthcare providers to extend care beyond the hospital walls, facilitating home-based oxygen therapy and reducing the burden on healthcare facilities. Additionally, POCs can be a cost-effective solution compared to traditional oxygen therapy methods, as they eliminate the need for frequent cylinder refills or stationary concentrator maintenance.
The growing preference for home-based medical care
Home-based medical care emphasizes the need for portable medical devices that enable patients to receive treatment without being confined to a hospital or clinic. POCs align with this requirement by providing a convenient and lightweight solution for delivering oxygen therapy at home. As a result, the growing preference for home-based care is escalating the demand for portable oxygen concentrators. Moreover, home-based medical care offers potential cost savings for healthcare systems by reducing hospital stays, readmissions, and emergency department visits. POCs enable patients to receive oxygen therapy at home, minimizing the need for hospital admissions related to respiratory conditions. This optimization of healthcare resources and cost-effectiveness is a driving factor in the integration of POCs into home-based care strategies.
The increasing geriatric population
As individuals age, the risk of developing respiratory conditions such as chronic obstructive pulmonary disease (COPD), pneumonia, and other lung-related ailments increases. These conditions often require long-term oxygen therapy to manage symptoms and improve the quality of life. Consequently, the rising geriatric population directly contributes to the increased prevalence of respiratory diseases, leading to a higher demand for POCs as an essential medical device for oxygen therapy. Moreover, POCs offer the necessary mobility and portability for the elderly population to continue their active lifestyle while receiving the oxygen support they require. The desire for active aging among the geriatric population drives the demand for POCs that enable them to participate fully in their desired activities.
IMARC Group provides an analysis of the key trends in each segment of the global portable oxygen concentrators market report, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on technology, application, and end user.
Continuous Flow
Pulse Flow
Pulse flow presently dominates the market
The report has provided a detailed breakup and analysis of the market based on technology. This includes continuous flow and pulse flow. According to the report, pulse flow represented the largest segment.
Pulse flow POCs operate by delivering oxygen in a pulsed or intermittent fashion, synchronized with the patient's inhalation. This intermittent delivery method allows for significant battery savings compared to continuous flow POCs. By delivering oxygen only when the patient breathes in, pulse flow POCs conserve energy, resulting in extended battery life. This feature is highly valued by users as it provides them with greater mobility and independence, allowing them to use the POC for longer durations without the need for frequent recharging or battery replacements. Moreover, these POCs are typically smaller, lighter, and more compact compared to continuous flow devices. This compact design enhances portability and ease of use, enabling users to carry the POC with them wherever they go. The lightweight nature and smaller size of pulse flow POCs contribute to their popularity among individuals who require oxygen therapy while maintaining an active lifestyle or traveling.
Chronic Obstructive Pulmonary Disease (COPD)
Asthma
Respiratory Distress Syndrome
Sleep Apnea
Others
Chronic obstructive pulmonary disease (COPD) represents the leading segment
A detailed breakup and analysis of the market based on the application has also been provided in the report. This includes chronic obstructive pulmonary disease (COPD), asthma, respiratory distress syndrome, sleep apnea, and others. According to the report, chronic obstructive pulmonary disease (COPD) represented the largest segment.
COPD is a prevalent respiratory disease globally, with a significant number of individuals diagnosed with the condition. The high prevalence of COPD directly translates to a larger patient base in need of oxygen therapy, driving the demand for POCs. Oxygen therapy plays a crucial role in managing COPD and improving patients' quality of life as many individuals with COPD require long-term oxygen therapy to maintain adequate oxygen levels and alleviate symptoms such as shortness of breath. Besides, the POC market has witnessed significant technological advancements, improving the performance, efficiency, and convenience of POCs for COPD patients. Advanced sensors, algorithms, and control systems in POCs enable precise oxygen delivery, synchronization with the patient's breath, and extended battery life. These technological advancements enhance the user experience, making POCs more user-friendly and reliable for COPD patients.
Hospitals
Ambulatory Surgery Centers
Others
Ambulatory surgery centers hold the largest share in the market
A detailed breakup and analysis of the market based on the end user has also been provided in the report. This includes hospitals, ambulatory surgery centers, and others. According to the report, ambulatory surgery centers represented the largest segment.
ASCs have witnessed significant growth and popularity in recent years due to various advantages they offer. ASCs provide a cost-effective alternative to inpatient hospital stays, allowing patients to undergo surgical procedures in a more efficient and comfortable setting. The increasing number of ASCs globally directly contributes to the larger customer base and demand for POCs in these facilities. Moreover, many surgical procedures performed in ASCs require the administration of supplemental oxygen to ensure patient safety and comfort. POCs are the preferred choice for oxygen therapy in ASCs due to their portability, ease of use, and convenience. The compact size and mobility of POCs make them well-suited for use in outpatient settings, enabling patients to receive oxygen therapy while moving around the facility.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance, accounting for the largest portable oxygen concentrators market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market.
North America has a significant prevalence of respiratory diseases, such as chronic obstructive pulmonary disease (COPD), asthma, and other lung-related ailments. The region's aging population, environmental factors, and lifestyle choices contribute to the higher occurrence of respiratory conditions. The greater prevalence of these diseases creates a larger patient base in need of oxygen therapy, driving the demand for POCs in North America. Moreover, the region boasts a well-developed healthcare infrastructure, characterized by advanced medical facilities, a robust healthcare system, and significant investments in healthcare research and development. The presence of advanced hospitals, clinics, and ambulatory surgery centers creates a conducive environment for the adoption of POCs. Besides, the POC market has witnessed continuous technological advancements, and North America has been at the forefront of these innovations. The region is home to several key players in the healthcare and medical device industry, fostering a culture of research and development.
The competitive landscape of the market is characterized by the presence of several key players competing to gain market share. These companies strive to develop innovative products, expand their distribution networks, and provide comprehensive after-sales support. Nowadays, the leading players are investing in research and development (R&D) activities to develop advanced product variants. They are also designing a diverse range of POC models designed for both home and travel use. Moreover, various key players are engaging in collaborations and mergers and acquisitions (M&As) to strengthen their market foothold and gain a competitive edge in the market.
Caire Inc. (NGK Spark Plug Co. Ltd)
Chart Industries Inc.
Drive Devilbiss Healthcare Limited (Drive International LLC)
Inogen Inc.
Invacare Corporation
Koninklijke Philips N.V
Nidek Medical India Pvt Ltd
O2 Concepts LLC
Precision Medical Inc. (BioHorizons Inc.)
Resmed Inc.
Teijin Limited
Philips Respironics, a subsidiary of Philips company, is introducing a range of POCs with advanced features such as extended battery life, user-friendly interfaces, and connectivity options.
Inogen Inc., a leading manufacturer of POCs specializing in lightweight and portable devices, is focusing on direct-to-consumer sales and providing excellent customer service to strengthen its market foothold.
ResMed Inc., a leading provider of medical devices and solutions for sleep apnea and respiratory disorders, has expanded its portfolio to include POCs that offer advanced features, comfort, and efficient oxygen delivery. The company is also integrating technology and data connectivity to enhance patient monitoring and therapy management.